The Natural History of Atopic Disease in Thai Children and Association With Atopic March
NCT02532920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2016-09-22
Summary
Atopic dermatitis(AD) is one of manifestation in atopic march. The prevalence of AD is increased. In 1998, the investigators found the prevalence of AD about 15 % in Thailand. AD is diagnosed by clinical as Hanifin and Rajka criteria. There are 3 group of severity defined by SCORAD(Scoring Atopic Dermatitis) : mild (\<25), moderate (25-50) and severe (\>50). The natural history of AD was mentioned in 3 groups: complete remission, persistent and intermittent. Atopic march is the progression of atopic disease that has atopic dermatitis as the first manifestation then patients will have allergic rhinitis or asthma in the future. The investigators do a retrospective study to understand the natural history of AD as well as it associate with atopic march. That might be a predictive factor of AD and atopic march
Conditions
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Principal Investigators
-
Orathia Piboonpocanun, professor · Siriraj Hospital
Eligibility
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- Thailand
Study Locations
More Related Trials
-
The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study
NCT02028546 ·Status: COMPLETED ·Phase: NA
-
Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis Children
NCT06947252 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Comprehending Atopic Risk Elements
NCT04325451 ·Status: UNKNOWN
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
The Factors Affecting Atopic Dermatitis in Children Age 1-3
NCT04218877 ·Status: COMPLETED
-
Sublingual Immunotherapy in Patients With Atopic Dermatitis
NCT01471119 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
NCT01782729 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT04162899 ·Status: COMPLETED ·Phase: PHASE2
-
Atopic Dermatitis Adherence Study
NCT02169986 ·Status: UNKNOWN ·Phase: NA
-
Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children
NCT05613062 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis
NCT01828879 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
NCT02916888 ·Status: COMPLETED
-
Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis
NCT03907228 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Pediatric Skin Disorders: The "Big" Study
NCT03544866 ·Status: COMPLETED
-
Text Messaging and Atopic Dermatitis
NCT01216059 ·Status: COMPLETED ·Phase: NA
-
Frequency of Palpebral Involvement in Adult With Atopic Dermatitis
NCT04826744 ·Status: RECRUITING
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants
NCT02401178 ·Status: COMPLETED
-
Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence
NCT02193230 ·Status: COMPLETED
-
Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)
NCT03823794 ·Status: COMPLETED
-
Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis
NCT00882245 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
NCT00438022 ·Status: COMPLETED
-
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS
NCT05783453 ·Status: COMPLETED
-
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
NCT00125333 ·Status: COMPLETED ·Phase: PHASE1/PHASE2